• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.03% Nasdaq Up1.29%

    Actavis plc (ACT)

    -NYSE
    289.74 Up 6.88(2.43%) May 1, 4:03PM EDT
    |After Hours : 291.50 Up 1.76 (0.61%) May 1, 6:01PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Actavis plc
    Euro House
    Euro Business Park
    Little Island,
    Ireland - Map
    Phone: 353 21 461 9040
    Fax: 353 21 461 9049
    Website: http://www.actavis.ie

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drugs - Generic
    Full Time Employees:21,600

    Business Summary 

    Actavis plc develops, manufactures, and sells generic, brand, and biosimilar pharmaceuticals. It offers over-the-counter products. The company also provides biosimilar products in women’s health, oncology, and other therapeutic categories. In addition, it offers pharmaceutical products in the areas of urology, gastroenterology, and dermatology therapeutic categories. The company produces medicines in various formulations, including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids, and semi-solids. It sells its products in Ireland and internationally. Actavis plc was founded in 1983 and is based in Little Island, Ireland. The company has development and manufacturing facilities in Europe, the United States, and Asia.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Actavis plc

    Corporate Governance 
    Actavis plc’s ISS Governance QuickScore as of Apr 1, 2015 is 8. The pillar scores are Audit: 10; Board: 4; Shareholder Rights: 4; Compensation: 8.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Paul M. Bisaro , 54
    Exec. Chairman
    5.37M55.23M
    Mr. Robert A. Stewart , 47
    Chief Operating Officer
    N/AN/A
    Mr. Brenton L. Saunders J.D., 45
    Chief Exec. Officer, Pres and Director
    N/AN/A
    Ms. Maria Teresa Hilado , 50
    Chief Financial Officer
    N/AN/A
    Mr. James C. D'Arecca , 44
    Chief Accounting Officer and VP
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders